Target intelligence / Profile preview

Rotavirus outer capsid glycoprotein VP7 and spike protein VP4 (VP7 and VP4)

Target
VP7 and VP4
Molecular classification
Viral protein, Glycoprotein, Spike protein, Capsid protein
01

Overview

The Rotavirus outer capsid glycoprotein VP7 and spike protein VP4 are the two primary structural proteins forming the outermost layer of the rotavirus virion [6, 15]. VP4 functions as a spike protein that mediates viral attachment to host cells and is proteolytically cleaved by trypsin into VP8* and VP5* subunits to facilitate membrane penetration [5, 12]. VP7 is a calcium-dependent glycoprotein that forms the bulk of the outer capsid and interacts with host co-receptors, such as integrins, to mediate viral entry and subsequent uncoating (decapsidation) within the host cell [2, 4, 16]. These proteins are the principal targets for neutralizing antibodies and serve as the basis for the G (glycoprotein) and P (protease-sensitive) dual classification system for rotavirus strains [1, 7, 14]. Therapeutic strategies, primarily live-attenuated vaccines like Rotarix and RotaTeq, target these proteins to elicit protective immunity against severe gastroenteritis in infants [8, 13, 18]. Ongoing research also explores monoclonal antibodies and subunit vaccines targeting specific domains of VP4 and VP7 to overcome challenges like antigenic diversity and vaccine-escape mutants [10, 13, 19].

Other names
G proteinP proteinOuter capsid proteinsVP7 glycoproteinVP4 spike proteinNeutralization antigens
02

Mechanism of action

Induction of neutralizing antibodies that inhibit viral attachment, membrane penetration, and virion decapsidation [5, 16, 18].

03

Biological functions

Viral attachmentCell entryMembrane penetrationVirion decapsidationImmune response induction
04

Disease associations

InfectionGastroenteritisDiarrhea
05

Safety considerations

IntussusceptionAntigenic driftVaccine escapeReversion to virulence
06

Interacting drugs

Rotarix

4 more in the full profile.

07

Biomarkers

VP7 genotype (G-type)VP4 genotype (P-type)Serum neutralizing antibody titers

Beyond the preview

Go deeper on Rotavirus outer capsid glycoprotein VP7 and spike protein VP4 (VP7 and VP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rotavirus outer capsid glycoprotein VP7 and spike protein VP4 (VP7 and VP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call